IL-6 enhances IgE-dependent histamine release from human peripheral blood-derived cultured mast cells.
We examined whether interleukin (IL)-6 exerts the stimulatory effects on the secretion of histamine from human mast cells triggered by crosslinking of the high affinity IgE receptor (FcepsilonRI) with IgE and anti-IgE. As target cells, we used peripheral blood-derived cultured mast cells grown with SCF, because they were superior in FcepsilonRIalpha expression to cord blood-derived mast cells. Incubation with SCF+IL-6 for 1 week increased the IgE-dependent release as well as intracellular content of histamine in the cultured mast cells, as compared with the values obtained by incubation with SCF alone. The magnitude of these increases was higher than that for priming with SCF+IL-4. A striking difference was also found in the expression of FcepsilonRIalpha between the two-factor combinations. The addition of IL-6 during FcepsilonRI crosslinking with IgE/anti-IgE in the presence of SCF did not influence histamine secretion. When SCF, IL-6 and IL-4 were used together, a further increase was observed in the anti-IgE-dependent liberation of histamine from the cultured mast cells, compared with the two-factor combinations. These results suggest that IL-6 functions as a secretagogue for the inflammatory mediator of human mast cells in the presence of SCF.
Kikuchi
Toshimi
T
Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.
Ishida
Shuichi
S
Kinoshita
Tatsuya
T
Sakuma
Shozo
S
Sugawara
Naoto
N
Yamashita
Tetsuji
T
Koike
Kenichi
K
D006632:Histamine / Q000378:metabolism; D006636:Histamine Release / Q000502:physiology*; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology / Q000378:metabolism*; D015850:Interleukin-6 / Q000378:metabolism*; D008407:Mast Cells / Q000276:immunology / Q000378:metabolism*; D017455:Receptors, IgE / Q000378:metabolism
D015850:Interleukin-6; D017455:Receptors, IgE; D007073:Immunoglobulin E; D006632:Histamine